919110-85-3

Upstream product

• 264881-37-0 5-Benzyloxy-3-bromo-1,4-naphthoquinone 
• 919110-84-2 chrysophanol-8-benzyl ether 

Downstream Products

• 919110-91-1 (R)-4-Benzyloxy-1-(8-benzyloxy-1-isopropoxy-9,10-dimethoxy-3-methyl-anthracen-2-yl)-4-methyl-hex-2-yn-1-ol 
• 919110-92-2 8-Benzyloxy-2-((R)-4-benzyloxy-1-hydroxy-4-methyl-hex-2-ynyl)-1-isopropoxy-3-methyl-anthraquinone 
• 919110-93-3 8-Benzyloxy-2-((R)-4-benzyloxy-4-methyl-hex-2-ynoyl)-1-isopropoxy-3-methyl-anthraquinone 
• 919110-81-9 2-((R)-4-Benzyloxy-4-methyl-hex-2-ynoyl)-1,8-dihydroxy-3-methyl-anthraquinone 
• 919110-94-4 2-(1-benzyloxy-1-methyl-propyl)-11-hydroxy-5-methyl-1-oxa-benzo[a]anthracene-4,7,12-trione 
• 919110-82-0 8-benzyloxy-2-bromo-1-isopropoxy-9,10-dimethoxy-3-methyl-anthracene 

Relevant academic research and scientific papers

Total synthesis of the proposed structure of the anthrapyran metabolite δ-indomycinone

The first total synthesis of the proposed structure of δ-indomycinone has been accomplished. The key steps involve the Diels-Alder reaction of a bromonaphthoquinone (6) and 1-methoxy-3-methyl-1-trimethylsiloxy-1,3-butadiene (7) to access the anthraquinone

First enantioselective total synthesis and structure determination of the anthrapyran metabolite γ-indomycinone

(Diagram presented) The first total synthesis of (R)-γ-indomycinone has been achieved which allowed the determination of the configuration of the stereogenic center of natural γ-indomycinone as (S). The approach stands out for its generality and efficienc